Skip to navigation Skip to content

The Cancer Letter

Inside information on cancer research and drug development

  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
  • Current Issue
    • Past Issues
  • Events
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter

The Cancer Letter

Inside information on cancer research and drug development

  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
  • Current Issue
    • Past Issues
  • Events
Frederick National Lab manufactures CAR T cells for multicenter trials
NCI Director's Report

Frederick National Lab manufactures CAR T cells for multicenter trials

NCI has established a program at Frederick National Laboratory to manufacture CAR T-cell therapies for multicenter clinical trials.
March 19, 2021
Vol.47 No.11
By Alexandria Carolan
NCI raises paylines, commemorates 50th anniversary of the National Cancer Act of 1971
NCI Director's Report

NCI raises paylines, commemorates 50th anniversary of the National Cancer Act of 1971

Pandemic notwithstanding, NCI is on track to reach the 15th percentile for the payline by 2025—a goal set by institute Director Ned Sharpless in response to a deluge of grant applications.
February 12, 2021
Vol.47 No.06
By Alexandria Carolan and Matthew Bin Han Ong
Sharpless: “This is one of the most uncertain budget environments that I think the NCI has ever experienced.”
NCI Director's Report

Sharpless: “This is one of the most uncertain budget environments that I think the NCI has ever experienced.”

NCI has joined a nationwide initiative to increase the number of underrepresented minority faculty at NIH-funded cancer hospitals.
December 04, 2020
Vol.46 No.45
By Alexandria Carolan
Ned Sharpless: “Nothing will stop us”—NCI commemorates 50th anniversary of the National Cancer Act
NCI Director's Report

Ned Sharpless: “Nothing will stop us”—NCI commemorates 50th anniversary of the National Cancer Act

NCI plans to mark the 50th anniversary of the National Cancer Act of 1971 with an effort to build a coalition of support for cancer research, including raising the payline to 15% by 2025.
October 16, 2020
Vol.46 No.39
By Alexandria Carolan
Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and colorectal cancers over 10 years
FreeNCI Director's Report

Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and colorectal cancers over 10 years

This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.
June 19, 2020
Vol.46 No.25
By Matthew Bin Han Ong
Sharpless: COVID-19 threatens to reverse long-running trend of decreasing cancer mortality
FreeNCI Director's Report

Sharpless: COVID-19 threatens to reverse long-running trend of decreasing cancer mortality

This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.
May 15, 2020
Vol.46 No.20
By Matthew Bin Han Ong
Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response
FreeNCI Director's Report

Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response

This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full directory of our coverage is available here.
April 14, 2020
Vol.46 No.16
By Matthew Bin Han Ong
Sharpless addresses three big issues in cancer in 2020:
NCI Director's Report

Sharpless addresses three big issues in cancer in 2020:

The pace of innovation in oncology has made U.S. cancer researchers prime targets for foreign state-sponsored programs aimed at diverting intellectual property.
February 14, 2020
Vol.46 No.07
By Matthew Bin Han Ong
Sharpless reflects on his time at FDA: “The engine producing new cancer therapies and diagnostics is doing very well”
NCI Director's Report

Sharpless reflects on his time at FDA: “The engine producing new cancer therapies and diagnostics is doing very well”

The progress in cancer exceeds that of any other therapeutic area right now—at least as far as FDA is concerned, NCI Director Ned Sharpless said at a Dec. 3 joint meeting of the Board of Scientific Advisors and the National Cancer Advisory Board.
December 06, 2019
Vol.45 No.45
By Matthew Bin Han Ong
Lowy: NCI needs 15% budget increase to reach FY2021 goal of 15th percentile for paylines
NCI Director's Report

Lowy: NCI needs 15% budget increase to reach FY2021 goal of 15th percentile for paylines

NCI is requesting an increase of $989 million to its FY2021 budget over FY2019 appropriated levels to boost the institute's payline, which has dropped to the 8th percentile in FY19—lower than 2013 sequestration levels—and which has been steadily dropping despite increased overall funding in recent years.
September 06, 2019
Vol.45 No.33
By Matthew Bin Han Ong

Posts navigation

1 2 Next

Trending Stories

  • Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
  • Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
  • Biden commits to creating “ARPA-H” research body in visit to Ohio State
  • Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
  • The Cancer Letter gets a new website
  • Abecma receives FDA approval for multiple myeloma
ABOUT
ABOUT
About The Cancer Letter
Our Contributors
Editorial policies
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2021 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Twitter
LinkedIn
Facebook
Vimeo
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation
Login

Forgot your password?

Looking for IP Login?

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No